(-)-Deprenyl, a monoamine oxidase (MAO)-B inhibitor, has been shown to
increase neuronal survival and to alter protein synthesis and gene ex
pression in astrocytic or PG12 cells independently of MAO-B inhibition
. We used serum and nerve growth factor withdrawal to induce apoptotic
death in PC12 cells to determine whether (-)-deprenyl increases neuro
nal survival by reducing apoptosis. (-)-Deprenyl reduced both cell dea
th and internucleosomal DNA degradation in a concentration-dependent m
anner and was effective at concentrations too low to inhibit MAO (< 10
(-9) M). (+)-Deprenyl did not increase PC12 cell survival, and, with t
he exception of pargyline, other MAO-A and MAO-B inhibitors did not al
ter apoptotic death. Transcriptional and translational inhibition show
ed that the reduction in apoptosis required the induction of new prote
in synthesis by (-)-deprenyl. Increased survival was induced a transcr
iption was maintained for 4 h and translation for 6 h after (-)-depren
yl addition. The findings suggest that transcriptional induction may u
nderlie the other MAO-independent actions of (-)-deprenyl.